Last update 30 Aug 2025

INXN-3004

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
AntiCD33 chimeric antigen receptor T cell therapy PGEN Therapeutics, AntiCD33chimericantigenreceptorTcellTherapy Precigen Inc/ZIOPHARM, INXN 3004
+ [1]
Target
CD33
Action
inhibitors
Mechanism
CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors), Gene transference(Gene transference), T lymphocyte replacements
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Myeloid Leukemia
Originator Organization
Precigen, Inc.Precigen, Inc.Alaunos Therapeutics, Inc.Alaunos Therapeutics, Inc.
Active Organization-
Inactive Organization
Anderson UniversityAnderson UniversityAlaunos Therapeutics, Inc.Alaunos Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with INXN-3004
Login to view more data
100 Translational Medicine associated with INXN-3004
Login to view more data
100 Patents (Medical) associated with INXN-3004
Login to view more data
100 Deals associated with INXN-3004
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
United States
Alaunos Therapeutics, Inc.Alaunos Therapeutics, Inc.
-
Acute Myeloid LeukemiaPhase 1
United States
Anderson UniversityAnderson University
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free